Clinical Diagnostics Imaging Articles & Analysis
4 news found
The scope of the Positron/Neusoft agreement is to further develop the utilization of its PET/CT technology and services for nuclear cardiology while expanding into the field of oncology imaging diagnostics and clinical services. The U.S. is the largest total addressable market for both cardiology and oncology fields and will continue to be ...
TeraRecon's multi-specialty advanced visualization solution, Intuition Titanium, will be fully integrated with Pixeon's PACS, known as Pixeon Aurora. With full clinical functionality for radiologists, cardiologists, vascular surgeons, and other specialty clinicians, the end-to-end solution will deliver premium imaging analysis tools and optimized workflows to ...
Under Sorenson leadership, TeraRecon: Achieved an impressive, delighted customer base of over 900 health systems and 5,000+ installations across 74 countries Established 3D advanced visualization-based planning as the gold standard for critical procedures like endovascular surgical planning Achieved consistent number one ranking as a KLAS category leader in radiology advanced visualization ...
CTT1057, a positron emission tomography (PET) imaging agent, discovered by Dr. Cliff Berkman, Professor of Chemistry at Washington State University and CTT Chief Scientific Officer, may be well-suited for imaging the location of cancer metastases that have escaped the prostate gland. ...